CN Stock MarketDetailed Quotes

688363 Bloomage Biotechnology Corporation Limited

Watchlist

48.75
-0.25-0.51%

Market Closed May 12 15:00 CST

23.48BMarket Cap716.91P/E (TTM)

Bloomage Biotechnology Corporation Limited Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

Assets

Current assets

Money funds

-18.55%680.99M

-38.46%719.27M

-54.62%511.52M

-48.47%657.89M

-39.78%836.13M

-27.23%1.17B

9.51%1.13B

-27.15%1.28B

-22.62%1.39B

-11.10%1.61B

Transactional financial assets

----

-78.56%30.02M

-57.24%30.03M

-57.25%30.04M

----

-73.61%140.04M

-91.75%70.24M

-86.70%70.26M

-37.84%200.15M

-37.33%530.72M

Notes receivable and accounts receivable

-8.27%522.98M

21.63%544.14M

2.17%532.02M

6.11%583.83M

17.02%570.11M

-0.24%447.36M

13.56%520.72M

40.00%550.23M

31.59%487.18M

11.76%448.44M

-Notes receivable

--1.26M

----

-Accounts receivable

-8.49%521.71M

21.35%542.88M

2.17%532.02M

6.11%583.83M

17.02%570.11M

-0.24%447.36M

13.56%520.72M

40.00%550.23M

31.59%487.18M

13.06%448.44M

Other receivables (including interest and dividends)

-16.40%49.06M

14.83%45.27M

30.62%53.18M

0.46%43.26M

22.15%58.68M

-24.06%39.42M

5.32%40.72M

38.91%43.06M

49.98%48.04M

79.61%51.91M

-Other receivable

----

14.83%45.27M

----

0.46%43.26M

----

-24.06%39.42M

----

38.91%43.06M

----

79.61%51.91M

Advance payment

-37.03%119.14M

-45.70%81.42M

-9.42%180.49M

-5.69%168.27M

-12.09%189.21M

-12.71%149.94M

-2.68%199.26M

9.91%178.42M

70.24%215.23M

94.78%171.76M

Inventories

5.74%1.23B

9.98%1.25B

9.83%1.32B

1.62%1.19B

-1.57%1.16B

-2.33%1.13B

11.14%1.2B

22.68%1.18B

45.37%1.18B

63.80%1.16B

Receivable financing

14.86%8.44M

14.76%3.24M

-90.56%936.26K

220.44%17.63M

8.06%7.35M

-70.05%2.83M

1,460.83%9.92M

1,432.83%5.5M

783.20%6.8M

893.03%9.43M

Other current assets

153.81%44.97M

73.64%69.55M

40.89%59.03M

255.86%53.91M

-19.69%17.72M

-7.22%40.05M

321.32%41.9M

38.31%15.15M

-79.54%22.06M

-57.76%43.17M

Total current assets

-6.59%2.65B

-12.24%2.74B

-16.37%2.68B

-17.06%2.75B

-19.94%2.84B

-22.38%3.12B

-12.62%3.21B

-13.61%3.31B

-0.50%3.55B

0.98%4.02B

Non Current assets

Other equity investment

8.69%53M

18.95%53.01M

-24.53%48.75M

-24.50%48.78M

62.54%48.76M

48.54%44.56M

115.31%64.59M

95.77%64.61M

--30M

Other non-current financial assets

79.06%85.5M

75.99%84M

48.05%47.58M

48.79%47.82M

48.59%47.75M

48.52%47.73M

--32.14M

Fixed assets

----

38.84%3.34B

----

19.31%2.33B

----

26.50%2.4B

----

13.92%1.95B

----

18.03%1.9B

Constru in process

----

-42.19%640.98M

----

27.59%1.48B

----

33.52%1.11B

----

80.16%1.16B

----

60.71%830.45M

Intangible assets

-1.16%485.26M

-1.28%490.63M

0.38%488.65M

0.45%489.88M

4.24%490.96M

4.61%496.97M

7.25%486.82M

6.50%487.7M

1.35%470.98M

1.67%475.06M

Goodwill

-29.24%176.6M

-30.72%174.09M

0.90%250.97M

-0.80%249.44M

0.68%249.58M

1.64%251.28M

282.61%248.73M

285.73%251.44M

276.18%247.88M

268.15%247.22M

Long deferred expense

3.58%99.15M

2.25%100.34M

-14.92%89.1M

-13.35%94.84M

-15.64%95.72M

-15.71%98.14M

68.91%104.71M

229.67%109.45M

246.68%113.47M

265.60%116.43M

Deferred tax assets

6.55%339.61M

5.51%355.56M

-8.78%330.54M

-6.94%308.78M

-1.46%318.73M

11.37%336.98M

34.12%362.37M

26.85%331.8M

25.61%323.44M

22.95%302.59M

Usufruct assets

77.12%182.35M

92.49%196.72M

131.46%195.99M

143.89%206.52M

17.64%102.95M

3.54%102.19M

-19.75%84.68M

-23.64%84.68M

-29.72%87.52M

-15.54%98.7M

Other non current assets

-64.13%75.58M

-74.24%67.89M

-64.57%134.59M

-57.47%188.14M

-65.98%210.73M

-52.81%263.58M

-43.72%379.88M

-31.86%442.31M

2.31%619.34M

25.39%558.56M

Total non current assets

7.47%5.88B

10.64%5.92B

16.79%6.01B

16.09%5.87B

11.46%5.48B

14.78%5.35B

21.40%5.14B

26.50%5.05B

27.62%4.91B

32.36%4.66B

Total assets

2.67%8.54B

2.20%8.66B

4.05%8.69B

2.96%8.62B

-1.70%8.32B

-2.44%8.47B

5.61%8.35B

6.85%8.37B

14.10%8.46B

15.70%8.68B

Liabilities

Current liabilities

Short term loan

--119.17M

--49.92M

----

--139.74M

--139.2M

Notes payable and accounts payable

13.87%593.73M

17.00%819.97M

35.01%787.4M

0.83%656.41M

-14.34%521.4M

-17.39%700.81M

15.13%583.22M

2.70%650.99M

12.82%608.65M

22.82%848.34M

-Notes payable

----

-97.03%1.7M

-77.14%7.2M

-50.12%10.83M

-23.17%29.96M

6.00%57.27M

-32.78%31.5M

-Accounts payable

14.25%593.73M

18.22%819.97M

37.56%787.4M

5.70%656.41M

-5.75%519.7M

-15.09%693.61M

18.06%572.39M

4.40%621.03M

13.58%551.38M

26.87%816.84M

Contract liabilities

-7.84%70.38M

14.20%63.48M

13.33%77.48M

-13.33%64.73M

-9.62%76.36M

-17.95%55.58M

-2.76%68.36M

8.06%74.69M

47.96%84.49M

33.28%67.74M

Salaries payable

-1.48%132.4M

17.81%199.97M

-0.62%115.91M

1.11%128.39M

30.47%134.39M

-45.52%169.73M

-56.80%116.64M

-49.62%126.98M

-44.40%103.01M

2.45%311.53M

Taxs payable

-33.06%59.45M

-43.51%52.54M

-53.99%72.85M

-46.73%84.66M

8.64%88.81M

-15.08%93M

49.81%158.33M

-0.30%158.94M

-32.03%81.74M

-48.27%109.51M

Other payable (including interest and dividends)

49.25%50.55M

32.27%56.57M

-5.49%40.66M

352.18%218.38M

-64.70%33.87M

-38.62%42.77M

-31.72%43.02M

-7.12%48.3M

149.71%95.95M

36.34%69.68M

-Dividend payable

--1.92M

----

--181.78M

----

-Other payable

----

27.78%54.65M

----

-38.62%42.77M

----

-7.12%48.3M

----

36.34%69.68M

Non current liabilities due within one year

128.99%88.57M

-40.13%91.68M

-74.67%34.1M

-73.02%39.71M

-75.79%38.68M

69.76%153.13M

40.14%134.64M

51.78%147.16M

77.61%159.75M

4.81%90.2M

Other current liabilities

-27.95%6.59M

19.91%6.91M

45.85%7.83M

-24.79%6.44M

-2.37%9.14M

-26.44%5.77M

-34.72%5.37M

-0.12%8.56M

75.51%9.37M

29.94%7.84M

Adjustment items of current assets

----

---0.01

----

Total current liabilities

24.17%1.12B

9.85%1.34B

2.40%1.14B

-1.39%1.2B

-29.63%902.65M

-25.74%1.22B

-12.60%1.11B

-13.96%1.22B

23.83%1.28B

17.39%1.64B

Current liabilities

Deferred tax liabilities

-2.99%4.32M

-10.28%4.57M

-26.94%3.42M

-18.13%4.1M

-16.54%4.45M

-10.04%5.09M

50.57%4.69M

58.86%5.01M

74.24%5.33M

37.34%5.66M

Long term deferred income

16.98%251.72M

23.10%253.24M

15.34%227.17M

16.83%221.92M

12.95%215.19M

9.04%205.73M

4.21%196.96M

0.32%189.96M

5.86%190.52M

3.27%188.68M

Lease liabilities

141.72%154.43M

190.50%152.97M

184.44%175.07M

263.60%168.06M

67.03%63.89M

0.44%52.66M

41.81%61.55M

-7.96%46.22M

-48.24%38.25M

-24.86%52.42M

Total non current liabilities

60.73%458.74M

79.05%475.9M

87.55%498.52M

61.92%395.57M

20.20%285.41M

-25.07%265.79M

-22.49%265.81M

-30.32%244.3M

-35.25%237.44M

-11.49%354.73M

Total liabilities

32.95%1.58B

22.22%1.82B

18.86%1.63B

9.20%1.59B

-21.85%1.19B

-25.63%1.49B

-14.70%1.38B

-17.22%1.46B

8.39%1.52B

10.96%2B

Shareholders equity

Paid-in capital

0.00%481.68M

0.03%481.68M

0.12%481.68M

0.09%481.52M

0.23%481.09M

Capital reserve funds

0.17%3.86B

0.30%3.85B

0.53%3.85B

0.61%3.85B

1.22%3.85B

2.35%3.84B

2.60%3.83B

3.07%3.82B

3.14%3.8B

5.15%3.75B

Surplus reserve funds

0.00%253.81M

Retained profit

-5.52%2.55B

-0.31%2.45B

11.17%2.63B

14.35%2.61B

14.50%2.7B

13.86%2.45B

27.28%2.37B

37.92%2.29B

45.44%2.36B

51.77%2.16B

Less:Treasury stock

7.83%219.95M

107.74%219.95M

2,522.11%219.95M

--219.95M

--203.98M

--105.88M

--8.39M

----

Other composite income

-6.75%9.74M

-122.10%-4.32M

1,455.90%17.71M

-16.96%9.33M

207.63%10.45M

315.09%19.57M

95.96%-1.31M

136.64%11.24M

66.05%-9.71M

61.95%-9.1M

Shareholders equity without minority interests

-2.24%6.93B

-1.93%6.81B

1.34%7.02B

1.89%6.99B

2.97%7.09B

4.68%6.94B

9.97%6.93B

12.93%6.86B

14.49%6.88B

16.40%6.63B

Minority interests

-26.61%28.88M

-24.65%29.63M

-28.10%34.44M

-30.70%36.15M

-29.36%39.35M

-20.09%39.33M

1,237.95%47.89M

1,754.95%52.17M

6,858.37%55.7M

1,327.46%49.21M

Total shareholder equity

-2.38%6.96B

-2.06%6.84B

1.13%7.05B

1.64%7.02B

2.71%7.13B

4.50%6.98B

10.81%6.97B

13.85%6.91B

15.43%6.94B

17.19%6.68B

Total liabilityies and equity

2.67%8.54B

2.20%8.66B

4.05%8.69B

2.96%8.62B

-1.70%8.32B

-2.44%8.47B

5.61%8.35B

6.85%8.37B

14.10%8.46B

15.70%8.68B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Grant Thornton Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022
Assets
Current assets
Money funds	-18.55%680.99M	-38.46%719.27M	-54.62%511.52M	-48.47%657.89M	-39.78%836.13M	-27.23%1.17B	9.51%1.13B	-27.15%1.28B	-22.62%1.39B	-11.10%1.61B
Transactional financial assets	----	-78.56%30.02M	-57.24%30.03M	-57.25%30.04M	----	-73.61%140.04M	-91.75%70.24M	-86.70%70.26M	-37.84%200.15M	-37.33%530.72M
Notes receivable and accounts receivable	-8.27%522.98M	21.63%544.14M	2.17%532.02M	6.11%583.83M	17.02%570.11M	-0.24%447.36M	13.56%520.72M	40.00%550.23M	31.59%487.18M	11.76%448.44M
-Notes receivable	--1.26M	--1.26M	----	----	----	----	----	----	----	----
-Accounts receivable	-8.49%521.71M	21.35%542.88M	2.17%532.02M	6.11%583.83M	17.02%570.11M	-0.24%447.36M	13.56%520.72M	40.00%550.23M	31.59%487.18M	13.06%448.44M
Other receivables (including interest and dividends)	-16.40%49.06M	14.83%45.27M	30.62%53.18M	0.46%43.26M	22.15%58.68M	-24.06%39.42M	5.32%40.72M	38.91%43.06M	49.98%48.04M	79.61%51.91M
-Other receivable	----	14.83%45.27M	----	0.46%43.26M	----	-24.06%39.42M	----	38.91%43.06M	----	79.61%51.91M
Advance payment	-37.03%119.14M	-45.70%81.42M	-9.42%180.49M	-5.69%168.27M	-12.09%189.21M	-12.71%149.94M	-2.68%199.26M	9.91%178.42M	70.24%215.23M	94.78%171.76M
Inventories	5.74%1.23B	9.98%1.25B	9.83%1.32B	1.62%1.19B	-1.57%1.16B	-2.33%1.13B	11.14%1.2B	22.68%1.18B	45.37%1.18B	63.80%1.16B
Receivable financing	14.86%8.44M	14.76%3.24M	-90.56%936.26K	220.44%17.63M	8.06%7.35M	-70.05%2.83M	1,460.83%9.92M	1,432.83%5.5M	783.20%6.8M	893.03%9.43M
Other current assets	153.81%44.97M	73.64%69.55M	40.89%59.03M	255.86%53.91M	-19.69%17.72M	-7.22%40.05M	321.32%41.9M	38.31%15.15M	-79.54%22.06M	-57.76%43.17M
Total current assets	-6.59%2.65B	-12.24%2.74B	-16.37%2.68B	-17.06%2.75B	-19.94%2.84B	-22.38%3.12B	-12.62%3.21B	-13.61%3.31B	-0.50%3.55B	0.98%4.02B
Non Current assets
Other equity investment	8.69%53M	18.95%53.01M	-24.53%48.75M	-24.50%48.78M	62.54%48.76M	48.54%44.56M	115.31%64.59M	95.77%64.61M	--30M	--30M
Other non-current financial assets	79.06%85.5M	75.99%84M	48.05%47.58M	48.79%47.82M	48.59%47.75M	48.52%47.73M	--32.14M	--32.14M	--32.14M	--32.14M
Fixed assets	----	38.84%3.34B	----	19.31%2.33B	----	26.50%2.4B	----	13.92%1.95B	----	18.03%1.9B
Constru in process	----	-42.19%640.98M	----	27.59%1.48B	----	33.52%1.11B	----	80.16%1.16B	----	60.71%830.45M
Intangible assets	-1.16%485.26M	-1.28%490.63M	0.38%488.65M	0.45%489.88M	4.24%490.96M	4.61%496.97M	7.25%486.82M	6.50%487.7M	1.35%470.98M	1.67%475.06M
Goodwill	-29.24%176.6M	-30.72%174.09M	0.90%250.97M	-0.80%249.44M	0.68%249.58M	1.64%251.28M	282.61%248.73M	285.73%251.44M	276.18%247.88M	268.15%247.22M
Long deferred expense	3.58%99.15M	2.25%100.34M	-14.92%89.1M	-13.35%94.84M	-15.64%95.72M	-15.71%98.14M	68.91%104.71M	229.67%109.45M	246.68%113.47M	265.60%116.43M
Deferred tax assets	6.55%339.61M	5.51%355.56M	-8.78%330.54M	-6.94%308.78M	-1.46%318.73M	11.37%336.98M	34.12%362.37M	26.85%331.8M	25.61%323.44M	22.95%302.59M
Usufruct assets	77.12%182.35M	92.49%196.72M	131.46%195.99M	143.89%206.52M	17.64%102.95M	3.54%102.19M	-19.75%84.68M	-23.64%84.68M	-29.72%87.52M	-15.54%98.7M
Other non current assets	-64.13%75.58M	-74.24%67.89M	-64.57%134.59M	-57.47%188.14M	-65.98%210.73M	-52.81%263.58M	-43.72%379.88M	-31.86%442.31M	2.31%619.34M	25.39%558.56M
Total non current assets	7.47%5.88B	10.64%5.92B	16.79%6.01B	16.09%5.87B	11.46%5.48B	14.78%5.35B	21.40%5.14B	26.50%5.05B	27.62%4.91B	32.36%4.66B
Total assets	2.67%8.54B	2.20%8.66B	4.05%8.69B	2.96%8.62B	-1.70%8.32B	-2.44%8.47B	5.61%8.35B	6.85%8.37B	14.10%8.46B	15.70%8.68B
Liabilities
Current liabilities
Short term loan	--119.17M	--49.92M	----	----	----	----	----	----	--139.74M	--139.2M
Notes payable and accounts payable	13.87%593.73M	17.00%819.97M	35.01%787.4M	0.83%656.41M	-14.34%521.4M	-17.39%700.81M	15.13%583.22M	2.70%650.99M	12.82%608.65M	22.82%848.34M
-Notes payable	----	----	----	----	-97.03%1.7M	-77.14%7.2M	-50.12%10.83M	-23.17%29.96M	6.00%57.27M	-32.78%31.5M
-Accounts payable	14.25%593.73M	18.22%819.97M	37.56%787.4M	5.70%656.41M	-5.75%519.7M	-15.09%693.61M	18.06%572.39M	4.40%621.03M	13.58%551.38M	26.87%816.84M
Contract liabilities	-7.84%70.38M	14.20%63.48M	13.33%77.48M	-13.33%64.73M	-9.62%76.36M	-17.95%55.58M	-2.76%68.36M	8.06%74.69M	47.96%84.49M	33.28%67.74M
Salaries payable	-1.48%132.4M	17.81%199.97M	-0.62%115.91M	1.11%128.39M	30.47%134.39M	-45.52%169.73M	-56.80%116.64M	-49.62%126.98M	-44.40%103.01M	2.45%311.53M
Taxs payable	-33.06%59.45M	-43.51%52.54M	-53.99%72.85M	-46.73%84.66M	8.64%88.81M	-15.08%93M	49.81%158.33M	-0.30%158.94M	-32.03%81.74M	-48.27%109.51M
Other payable (including interest and dividends)	49.25%50.55M	32.27%56.57M	-5.49%40.66M	352.18%218.38M	-64.70%33.87M	-38.62%42.77M	-31.72%43.02M	-7.12%48.3M	149.71%95.95M	36.34%69.68M
-Dividend payable	--1.92M	--1.92M	----	--181.78M	----	----	----	----	----	----
-Other payable	----	27.78%54.65M	----	----	----	-38.62%42.77M	----	-7.12%48.3M	----	36.34%69.68M
Non current liabilities due within one year	128.99%88.57M	-40.13%91.68M	-74.67%34.1M	-73.02%39.71M	-75.79%38.68M	69.76%153.13M	40.14%134.64M	51.78%147.16M	77.61%159.75M	4.81%90.2M
Other current liabilities	-27.95%6.59M	19.91%6.91M	45.85%7.83M	-24.79%6.44M	-2.37%9.14M	-26.44%5.77M	-34.72%5.37M	-0.12%8.56M	75.51%9.37M	29.94%7.84M
Adjustment items of current assets	----	----	----	----	----	----	----	----	---0.01	----
Total current liabilities	24.17%1.12B	9.85%1.34B	2.40%1.14B	-1.39%1.2B	-29.63%902.65M	-25.74%1.22B	-12.60%1.11B	-13.96%1.22B	23.83%1.28B	17.39%1.64B
Current liabilities
Deferred tax liabilities	-2.99%4.32M	-10.28%4.57M	-26.94%3.42M	-18.13%4.1M	-16.54%4.45M	-10.04%5.09M	50.57%4.69M	58.86%5.01M	74.24%5.33M	37.34%5.66M
Long term deferred income	16.98%251.72M	23.10%253.24M	15.34%227.17M	16.83%221.92M	12.95%215.19M	9.04%205.73M	4.21%196.96M	0.32%189.96M	5.86%190.52M	3.27%188.68M
Lease liabilities	141.72%154.43M	190.50%152.97M	184.44%175.07M	263.60%168.06M	67.03%63.89M	0.44%52.66M	41.81%61.55M	-7.96%46.22M	-48.24%38.25M	-24.86%52.42M
Total non current liabilities	60.73%458.74M	79.05%475.9M	87.55%498.52M	61.92%395.57M	20.20%285.41M	-25.07%265.79M	-22.49%265.81M	-30.32%244.3M	-35.25%237.44M	-11.49%354.73M
Total liabilities	32.95%1.58B	22.22%1.82B	18.86%1.63B	9.20%1.59B	-21.85%1.19B	-25.63%1.49B	-14.70%1.38B	-17.22%1.46B	8.39%1.52B	10.96%2B
Shareholders equity
Paid-in capital	0.00%481.68M	0.00%481.68M	0.00%481.68M	0.00%481.68M	0.03%481.68M	0.12%481.68M	0.12%481.68M	0.12%481.68M	0.09%481.52M	0.23%481.09M
Capital reserve funds	0.17%3.86B	0.30%3.85B	0.53%3.85B	0.61%3.85B	1.22%3.85B	2.35%3.84B	2.60%3.83B	3.07%3.82B	3.14%3.8B	5.15%3.75B
Surplus reserve funds	0.00%253.81M	0.00%253.81M	0.00%253.81M	0.00%253.81M	0.00%253.81M	0.00%253.81M	0.00%253.81M	0.00%253.81M	0.00%253.81M	0.00%253.81M
Retained profit	-5.52%2.55B	-0.31%2.45B	11.17%2.63B	14.35%2.61B	14.50%2.7B	13.86%2.45B	27.28%2.37B	37.92%2.29B	45.44%2.36B	51.77%2.16B
Less:Treasury stock	7.83%219.95M	107.74%219.95M	2,522.11%219.95M	--219.95M	--203.98M	--105.88M	--8.39M	----	----	----
Other composite income	-6.75%9.74M	-122.10%-4.32M	1,455.90%17.71M	-16.96%9.33M	207.63%10.45M	315.09%19.57M	95.96%-1.31M	136.64%11.24M	66.05%-9.71M	61.95%-9.1M
Shareholders equity without minority interests	-2.24%6.93B	-1.93%6.81B	1.34%7.02B	1.89%6.99B	2.97%7.09B	4.68%6.94B	9.97%6.93B	12.93%6.86B	14.49%6.88B	16.40%6.63B
Minority interests	-26.61%28.88M	-24.65%29.63M	-28.10%34.44M	-30.70%36.15M	-29.36%39.35M	-20.09%39.33M	1,237.95%47.89M	1,754.95%52.17M	6,858.37%55.7M	1,327.46%49.21M
Total shareholder equity	-2.38%6.96B	-2.06%6.84B	1.13%7.05B	1.64%7.02B	2.71%7.13B	4.50%6.98B	10.81%6.97B	13.85%6.91B	15.43%6.94B	17.19%6.68B
Total liabilityies and equity	2.67%8.54B	2.20%8.66B	4.05%8.69B	2.96%8.62B	-1.70%8.32B	-2.44%8.47B	5.61%8.35B	6.85%8.37B	14.10%8.46B	15.70%8.68B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	--	--	--	--	Grant Thornton Certified Public Accountants (Special General Partnership)	--	--	--	Grant Thornton Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

688363 Bloomage Biotechnology Corporation Limited

Bloomage Biotechnology Corporation Limited Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Market Insights

Discussing

Latest News

Investment Course